Publications
The following articles are provided by MSD as a service to the medical profession. These publications are copyrighted documents. MSD is authorized to distribute a copy of these articles for personal use only; they may not be passed on to third parties. Reproduction or distribution of copies is not permitted.
KN-483 publication
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial